GSK PLC News

6-K: Transaction Notification

Apr 17 10:54 ET

6-K: New Long-Term Data Show Shingrix Continues to Provide High Protection Against Shingles in Adults Aged 50 and over for More Than a Decade

Apr 17 06:14 ET

6-K: Gsk Today Announced Positive Results from the Pivotal Eagle-1 Phase Iii Trial for Gepotidacin

Apr 17 06:09 ET

6-K: The Following Amendments Have Been Made in Accordance with the “director/Pdmr Shareholdings” Announcement Issued by Rns No 6709k

Apr 16 09:55 ET

6-K: GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA

Apr 16 06:24 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 15 11:29 ET

GSK PLC | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)

Apr 4 07:50 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 2 13:20 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 26 07:49 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 25 09:43 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 22 12:52 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 22 12:22 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 18 09:59 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 13 13:19 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 8 12:50 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 7 06:14 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 6 11:13 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 5 06:13 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 1 10:34 ET

GSK PLC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 1 09:59 ET